Sarepta Therapeutics (SRPT) Current Taxes (2017 - 2026)

Sarepta Therapeutics' Current Taxes history runs 8 years deep, the most recent figure standing at $13.8 million for Q1 2026.

• In Q1 2026, Current Taxes fell 82.73% year-over-year to $13.8 million; the TTM figure through Mar 2026 stood at $13.8 million (down 82.73% YoY), while the FY2025 annual figure was $4.8 million, down 72.66% from the prior year.
• Current Taxes for Q1 2026 stood at $13.8 million, up from $4.8 million in the prior quarter.
• The five-year high for Current Taxes was $79.9 million in Q1 2025, with the low at $4.1 million in Q3 2022.
• The 5-year median for Current Taxes is $16.1 million (2023), against an average of $19.5 million.
• The sharpest annual moves came in 2022 and 2026: Current Taxes surged 5696.76% in 2022, then tumbled 82.73% in 2026.
• Sarepta Therapeutics' Current Taxes stood at $12.5 million in 2022, then climbed by 9.94% to $13.8 million in 2023, then gained by 26.33% to $17.4 million in 2024, then tumbled by 72.66% to $4.8 million in 2025, then jumped by 189.99% to $13.8 million in 2026.
• Business Quant data shows SRPT's Current Taxes at $13.8 million in Q1 2026, $4.8 million in Q4 2025, and $9.1 million in Q3 2025.